Disciples spreading the word

The Early Years, 1972-1986

Reading time: 8 minutes

The environment that Lars Leksell nurtured at the Seraphim Hospital and the Karolinska Institute became a hotbed for talented neurosurgeons from different parts of the world. They later became the strongest advocates for the disruptive methods in surgery that Leksell and Elekta proposed – and would help open many doors for Elekta during their own careers

Lars Leksell was a pioneering researcher and innovator. He was also keen to ensure that his scientific work would lead to applications that would be used and disseminated internationally. But he did not want to be in the limelight or do any pr-work for the technique, says his son Dan Leksell, himself a doctor and for many years responsible for research and development at Elekta.

“Dad was not particularly fond of traveling around the world and talking about what he did. He was quite shy and insecure when dealing with people and never spoke freely, preferring to use carefully prepared manuscripts.”

Dan’s brother Larry Leksell agrees and remembers a memory from the 1970s.

“Dad could be social and charming, but fundamentally he was quite shy and introverted. When he was older, he could sometimes take sick leave at short notice ahead of a lecture. I remember once when I was on a trip to Boston, where dad was to receive one of the finest medals in neurosurgery and was an honorary speaker. But shortly before the speech, he laid down in the hotel room and insisted that I take over. I only had a few key points to go on, so it was no easy task to deliver an unprepared speech in English in front of the world’s leading researchers in the field.”

Disciples around the world

But in his daily profession, Lars Leksell was a fervent communicator – and he gathered disciples and ambassadors for the stereotactic method and radiation surgery around him. His sons Dan and Larry Leksell along with a number of doctoral students became early external faces for the new technique.

“We continuously shuttled back and forth to all the congresses and lectured on new treatment methods and indications,” says Dan Leksell.

Lars Leksell planted ideas for potential developments in his students but then let them assume responsibility for their own projects.

“It was often the case that dad got an idea, for example using radiosurgery on acoustic tumors. He used radiosurgery in a single case, then waited for the results over six to twelve months and published a case report. He would then approach his assistants, in this case Georg Norén, and say: you should develop this indication. In this way, the message about the new technology spread around the world in a credible way and for a long time,” Dan Leksell explains.

Letting the students shine

One of Lars Leksell’s first students and close associates was Erik-Olof Backlund, known as “Backis”. He participated at an early stage of the development of radiosurgery and focused his research on stereotactic treatment of craniopharyngiomas and pituitary tumors. At the Nobel Symposium in 1968, Backlund lectured on the first successful clinical trials with Gamma Knife at the Sophiahemmet private hospital, a method that was considered controversial at the time.

Backlund defended his dissertation in 1972 and became an associate professor of neurosurgery and chief physician at the Karolinska Institute (KI). He became something of an international celebrity when he performed the first adrenal medulla tissue transplants to the brain for the treatment of Parkinson’s disease.

Another Leksell student was Björn Meyerson. He became a pioneer in functional neurosurgery, especially in the treatment of severe pain conditions through electrical stimulation of the nervous system. Eventually, Meyerson became head of the neurosurgery clinic at KI and professor of clinical pain research.

Leksell's student Sten Håkansson accidentally discovered a new treatment method for trigeminal neuralgia, a painful facial disease. It turned out that the injection of glycerol to the nerve had a pain-relieving effect. The method was the focus of Håkansson’s doctoral dissertation and was widely circulated internationally.

Tiit Rähn primarily studied radiotherapy of lesions in the pituitary area. Ladislau Steiner, who together with Lars Leksell introduced radiation surgery as an effective treatment for arteriovenous malformations, was responsible for general training in the neurosurgical technique. Christer Lindquist was also active in radiosurgery as well as microsurgery. Together with Steiner he introduced microsurgical techniques to the neurosurgery unit at KI. Over a number of years, special courses in radiosurgery were organized and were headed by, among others, Tiit Rähn, Christer Lindquist, Bodo Lippitz and Bengt Karlsson.

The importance of Dade Lunsford

But it was not only young Swedish researchers who were spreading the message about radiosurgery around the world. A decisive contribution was also made by the American Dade Lunsford. He graduated in medicine from Columbia University College of Physicians and Surgeons in 1974. A few years later, he was a guest researcher in stereotactic and functional neurosurgery at KI for a year and received his training from Lars Leksell and Erik-Olof Backlund. During his stay in Stockholm, Lunsford began to realize the potential of radiosurgery, thanks to his personal contact with Leksell, who had already retired at the time, but who liked to spend a lot of time at the clinic with his young colleagues.

Back in the U.S., Dade Lunsford started lecturing on the radiation knife and the potential of radiosurgery. In 1987, he ultimately managed to get the first Gamma Knife for clinical purposes installed in the U.S., at the University Hospital in Pittsburgh. Lunsford’s scientific work was an important contribution to the international breakthrough of Gamma Knife.

In recognition of his pioneering work in stereotactic surgery and radiosurgery, Dade Lunsford received the Herbert Olivecrona Award in 2017, commonly known as the “Nobel Prize in Neurosurgery”. He is today the holder of the Lars Leksell Professorship in Neurosurgery at the University of Pittsburgh.

Did you find it interesting?

Feel free to share it across social media!

Discover more of our story

The Early Years

1972 - 1986

A Company Grows Up

1986 - 1993

Important Turns

1994 - 2005

A Modern Approach

2005 - 2022

The Early Years

Neurosurgeon Lars Leksell invents Leksell Gamma Knife to treat brain cancer—without an open surgical procedure! Now, how will that impact traditional radiotherapy? Sons Larry and Danny help turn it all into a proper company.


Surgeon and inventor: Lars Leksell's brilliant mind

Elekta was founded in 1972 and is tightly connected to the vision of non-invasive brain surgery and non-invasive cancer treatment. Discover how Elekta started

You are here

Disciples spreading the word

The environment that Lars Leksell nurtured at the Seraphim Hospital and the Karolinska Institute became a hotbed for talented neurosurgeons from different parts of the world.


The knife in media

Elekta was founded in 1972 and is tightly connected to the vision of non-invasive brain surgery and non-invasive cancer treatment. Discover how Elekta started


A Company Grows Up

Finally, the first Gamma Knife sale! The treatment brings new hope to cancer patients, while Elekta figures out how to work with health care providers worldwide.


Entering the US market

Entering the US market was a do or die move for Elekta. It meant building trust and establishing a solution previously unheard of in a market with fierce competition.


Big in Japan

The introduction to the Japanese market was the most expensive in the company’s history.


A gate to China

Building trust in China and establishing the Asian headquarters in Hong Kong in 1994.


Members only

By encouraging the growing number of believers to develop and spread the message, Elekta convinced the world of the excellence of the Leksell Gamma Knife. The Leksell Gamma Knife Society became the platform for discussions and knowledge exchanges. And a key to the society’s success was that Dan Leksell ensured the doors stayed closed to Elekta’s own sales team and for non-customers.


Important Turns

A major acquisition paves the way for a broader Elekta way—because radiosurgery and radiotherapy can play well together.


The “Crawley Acquisition” of 1997

Elekta was founded in 1972 and is tightly connected to the vision of non-invasive brain surgery and non-invasive cancer treatment. Discover how Elekta started


A Modern Approach

A modern approach to cancer care, find out more about how Elekta's past has shaped its vision for the future, providing hope for those dealing with cancer


The IMPAC acquisition

When Elekta, in January 2005, announced its intention to acquire the Silicon Valley oncology software company IMPAC it seemed like the perfect match. And, in many ways, it was, but there were also two very different cultures moving in together.


Moving inside the body

Through the acquisition of the Dutch company Nucletron, Elekta gained a new vital business area - Brachy Solutions. For the management of Nucletron, the sale fulfilled the ambition to have more cancer patients benefit from brachytherapy.